A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Shanghai Jiao Tong University School of Medicine
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Thomas Jefferson University
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Yale University
Mayo Clinic
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Stanford University
Centre Oscar Lambret
Mayo Clinic
University of California, Irvine
TILT Biotherapeutics Ltd.
Ohio State University Comprehensive Cancer Center
Ossium Health, Inc.
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Essen Biotech
Dana-Farber Cancer Institute
Ohio State University Comprehensive Cancer Center